Sally Nijim, an MD/MBA candidate at the Perelman School of Medicine and the Wharton School and 2024 CDCN Biomedical Leadership Fellow at PSOM, was recognized with the Synchrony 2024 Best Research Presentation award for a podium presentation delivered at the BRAIN Foundation titled “Clinical Characterization of TCF7L2-Related Neurodevelopmental Disorder (TRND) in 75 Patients, the Largest Cohort Reported to Date.” The award included a cash prize of $5,000.

Ms. Nijim is the chief of staff and a biomedical leadership fellow for the team of David Fajgenbaum, an assistant professor of translational medicine & human genetics, at the Castleman Disease Collaborative Network (CDCN), the Center for Cytokine Storm Treatment & Laboratory (CSTL), and Every Cure. She also serves as a researcher in the Babushok lab at Penn.

Synchrony is an annual, international symposium on breakthrough medical research for the development of FDA-approved treatments for health conditions and core impairments found most commonly in people with autism and developmental disabilities. The goal of the BRAIN Foundation and Synchrony Symposia is to catalyze scientific research that can improve the quality of life for those with neurological disorders and developmental disabilities through safe and evidence-based medicine.